What is the suggested antithrombotic strategy for AF patients requiring OAC presenting with an ACS, undergoing PCI/stenting, where bleeding risk is low?
We suggest triple therapy for 6 months, followed by dual therapy with OAC plus single antiplatelet (preferably clopidogrel) until 12 months, following which OAC monotherapy can be used (Weak recommendation, low quality evidence).